Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03829059
Other study ID # GCG
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date June 1, 2018
Est. completion date February 2026

Study information

Verified date October 2023
Source Medical University of Graz
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This retrospective study will evaluate the patient collective of the Division of Oral Surgery and Orthodontics, Department of Dental Medicine and Oral Health and of the Division of Cranio-Maxillofacial Surgery at the Medical University Graz concerning the frequency of epulis/giant cell lesion or underlying differential diagnoses and immunophenotypes as well as the resulting treatment methods and their success and compare these with international results


Description:

Different histopathological differential diagnoses can underlay the clinical presentation of an epulis. Often the immunophenotype of these lesions is of particular importance. This also holds for the the central giant cell lesion. This study will evaluate the patient collective of the Division of Oral Surgery and Orthodontics, Department of Dental Medicine and Oral Health and of the Division of Cranio-Maxillofacial Surgery at the Medical University Graz concerning the frequency of epulis/giant cell lesion or underlying differential diagnoses and immunophenotypes as well as the resulting treatment methods and their success and compare these with international results. This is a retrospective study using electronic patient records, written records, operative reports of the Division of Oral Surgery and Orthodontics, Department of Dental Medicine and Oral Health and of the Division of Cranio-Maxillofacial Surgery at the Medical University Graz in the period from 1986 to March 2018. It is intended to gather the data within 12 months and analyze statistically subsequently.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 83
Est. completion date February 2026
Est. primary completion date February 2026
Accepts healthy volunteers No
Gender All
Age group 7 Years to 95 Years
Eligibility Inclusion Criteria: - existence of a medical history and a histopathological finding of the surgical specimen - patients treated in the outpatient clinic for diseases of oral mucosa of the Division of Oral Surgery and Orthodontics, Department of Dental Medicine and Oral Health and of the Division of Cranio-Maxillofacial Surgery at the Medical University Graz between 1986 and March 2018 Exclusion Criteria: - absence of a medical history or a histopathological finding.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Austria Medical University Graz

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Graz

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of histological pathological differential diagnoses. time period of evaluation from 1986 to March 2018
Primary Frequency of immunohistochemical pathological differential diagnoses. time period: from 1986 to March 2018
Primary Frequency of molecular pathological differential diagnoses. time period from 1986 to March 2018
Secondary Frequency of recurrences depending on differential diagnoses and therapy time period from 1986 to March 2018